Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleHealth Weight Solutions vs Wisp

TeleHealth Weight Solutions
Graded #302

Lower grade

vs+3.3000000000000043
Wisp
Graded #243

Higher grade

The verdict

Wisp takes it — 64.4/100 to 61.1/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +5
45
50
Dose & formulationWisp +4
72
76
Clinical oversightWisp +6
76
82
Labs & monitoringWisp +1
52
53
FulfillmentTeleHealth Weight Solutions +1
67
66
Contract termsEven
55
55
TeleHealth Weight Solutions · left barWisp · right bar

The numbers

MetricTeleHealth Weight SolutionsWisp
WeighScore61.1/10064.4/100
GradeCC
Scorecard rank#302#243
Semaglutide$325/mo (all doses, compounded)$225/mo (compounded oral)
Tirzepatide$375/moNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes

Strengths

  • Both compounded semaglutide and tirzepatide offered with published pricing
  • Low refill pricing (from about 60 dollars per month) after the initial supply
  • Broad advertised reach across 43 states with home delivery of medication and supplies

Where it loses points

  • Dispensing pharmacy is not publicly named
  • Specific states served are not listed and the site also shows a separate Medi Health Clinics brand
  • 125-dollar transfer fee for outside prescriptions
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard